Futures Open Int up Rs 1732 crore, Options Open Int up Rs 1030 crore Bazaar
* Nifty Sep futures add 4 lakh shares in Open Int, at 14-point premium
* Nifty Oct futures add 7 lakh shares in Open Int, at 27-point premium
* Nifty Open Int PCR at 1.84 versus 1.75
* Nifty Puts add 30 lakh shares, Calls shed 21 lakh shares in Open Int
* Nifty 5900 Put adds 26 lakh shares in Open Int
* Nifty 6000 Put adds 21 lakh shares in Open Int
* Nifty 5600 Put sheds 10 lakh shares in Open Int
* ifty 6100 Call adds 14.6 lakh shares in Open Int
* Nifty 5700 Call sheds 15 lakh shares in Open Int
* Nifty 5900 Call sheds 10.2 lakh shares in Open Int
* Stock futures add 2.2 crore shares in Open Int
Ranbaxy
Technical View
Ranbaxy has bullish trend. The stock made new high in the today`s session and closed on stronger notes. So above the resistance level of 566 some more upside may be seen in the stock. Shares of Ranbaxy Laboratories Ltd. climbed after the company got sole exclusive rights from the USFDA to sell a generic version Eisai Co.’s best-selling treatment for Alzheimer’s disease Aricept in the US. According to reports, Teva Pharmaceutical Industries Ltd.’s application to sell generic Aricept was changed from approved to tentatively approved effective Imediately, precluding the Israeli company from competing with Ranbaxy during the six-month period.
